Teva Pharmaceutical not to acquire ViroPharma - MarketLine Financial Deals

Teva Pharmaceutical not to acquire ViroPharma

Teva Pharmaceutical not to acquire ViroPharma - MarketLine Financial Deals
Teva Pharmaceutical not to acquire ViroPharma
Published Aug 26, 2009
2 pages — Published Aug 26, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Reuters, the US-based ViroPharma Incorporated has denied the media reports regarding its possible acquisition by an Israel-based Teva Pharmaceutical Industries, Ltd.

  
Source:
Document ID
MA08226_090828
Country
Country
Ticker
TEVA=IL
Ticker
VPHM=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Teva Pharmaceutical not to acquire ViroPharma" Aug 26, 2009. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-not-to-acquire-ViroPharma-2052-7933>
  
APA:
MarketLine Financial Deals. (2009). Teva Pharmaceutical not to acquire ViroPharma Aug 26, 2009. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Teva-Pharmaceutical-not-to-acquire-ViroPharma-2052-7933>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.